Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREOF

  • Read more about TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREOF
US Patent 5,606,060
Filed on 1995-06-02

TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREOF

  • Read more about TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREOF
US Patent 5,747,520
Filed on 1995-06-02

IMMUNOGENIC CHIMERAS COMPRISING NUCLEIC ACID SEQUENCES ENCODING EN- DOPLASMIC RETICULUM SIGNAL SEQUENCE PEPTIDES AND AT LEAST ONE...

  • Read more about IMMUNOGENIC CHIMERAS COMPRISING NUCLEIC ACID SEQUENCES ENCODING EN- DOPLASMIC RETICULUM SIGNAL SEQUENCE PEPTIDES AND AT LEAST ONE...
US Patent 5,733,548
Filed on 1995-06-05

BISTRIAZENES AS CHEMOTHERAPEUTIC AGENTS

  • Read more about BISTRIAZENES AS CHEMOTHERAPEUTIC AGENTS
US Patent 5,731,301
Filed on 1995-05-31

METHODS OF ASSESSING MHC CLASS I EXPRESSION AND PROTEINS CAPABLE OF MODULATING CLASS I EXPRESSION

  • Read more about METHODS OF ASSESSING MHC CLASS I EXPRESSION AND PROTEINS CAPABLE OF MODULATING CLASS I EXPRESSION
US Application 08/503,525
Filed on 1995-08-21

HUMAN CRIPTO-RELATED GENE

  • Read more about HUMAN CRIPTO-RELATED GENE
US Patent 5,650,285
Filed on 1995-06-05

MULTIDETERMINANT PEPTIDES THAT ELICIT HELPER T LYMPHOCYTE, CYTOTOXIC T LYMPHOCYTE AND NEUTRALIZING ANTIBODY RESPONSES AND DIAGNOSTIC METHODS

  • Read more about MULTIDETERMINANT PEPTIDES THAT ELICIT HELPER T LYMPHOCYTE, CYTOTOXIC T LYMPHOCYTE AND NEUTRALIZING ANTIBODY RESPONSES AND DIAGNOSTIC METHODS
US Application 08/455,701
Filed on 1995-05-31

MULTIDETERMINANT PEPTIDES ELICITING HELPER T-LYMPHOCYTE, CYTOTOXIC LYMPHOCYTE AND NEUTRALIZING ANTIBODY RESPONSES AGAINST HIV-1

  • Read more about MULTIDETERMINANT PEPTIDES ELICITING HELPER T-LYMPHOCYTE, CYTOTOXIC LYMPHOCYTE AND NEUTRALIZING ANTIBODY RESPONSES AGAINST HIV-1
US Patent 5,932,218
Filed on 1995-05-31

MULTIDETERMINANT PEPTIDES THAT ELICIT HELPER T LYMPHOCYTE, CYTOTOXIC T LYMPHOCYTE AND NEUTRALIZING ANTIBODY RESPONSES AGAINST HIV-1

  • Read more about MULTIDETERMINANT PEPTIDES THAT ELICIT HELPER T LYMPHOCYTE, CYTOTOXIC T LYMPHOCYTE AND NEUTRALIZING ANTIBODY RESPONSES AGAINST HIV-1
US Patent 6,214,347
Filed on 1995-05-31

VECTORS CARRYING MDR1 CDNA WHICH CONFER MULTIDRUG RESISTANCE ON TRANSDUCED CELLS

  • Read more about VECTORS CARRYING MDR1 CDNA WHICH CONFER MULTIDRUG RESISTANCE ON TRANSDUCED CELLS
US Application 08/455,169
Filed on 1995-05-31

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1561
  • Page 1562
  • Page 1563
  • Page 1564
  • Page 1565
  • Page 1566
  • Page 1567
  • Page 1568
  • Page 1569
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health